HIGHLIGHTS
- who: Report and colleagues from the Internal Medicine, University at Buffalo, Buffalo, USA Internal Medicine, Mercy Hospital St. Louis, St. Louis, USA have published the article: Review began 12/07/2022 Review ended 12/24/2022 Published 12/29/2022 u00a9 Copyright, in the Journal: (JOURNAL) of December/29,/2022
- what: BPDCN is an uncommon condition with no consensus standard treatment regimen until recently.
SUMMARY
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive condition involving the clonal proliferation of immature precursor plasmacytoid dendritic cells (pDCs). Sixty to ninety percent of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.